Kensington Investment Counsel’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-58,599
| Closed | -$342K | – | 84 |
|
|
2022
Q4 | $342K | Sell |
58,599
-18,202
| -24% | -$106K | 0.27% | 76 |
|
|
2022
Q3 | $515K | Buy |
76,801
+447
| +0.6% | +$3K | 0.43% | 71 |
|
|
2022
Q2 | $321K | Sell |
76,354
-395
| -0.5% | -$1.66K | 0.27% | 76 |
|
|
2022
Q1 | $259K | Sell |
76,749
-8,734
| -10% | -$29.5K | 0.17% | 86 |
|
|
2021
Q4 | $269K | Buy |
+85,483
| New | +$269K | 0.16% | 86 |
|
|
2021
Q2 | $356K | Buy |
84,368
+1,966
| +2% | +$8.3K | 0.24% | 82 |
|
|
2021
Q1 | $411K | Buy |
82,402
+6,869
| +9% | +$34.3K | 0.31% | 79 |
|
|
2020
Q4 | $955K | Buy |
+75,533
| New | +$955K | 0.79% | 65 |
|